Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Health Care & Life Sciences Consulting

See All Services Meet The Team

Overview

As a stakeholder in the health and life sciences industry, you work every day to extend the boundaries of human health and enhance patient care. With a bipartisan team of lobbyists and public policy professionals, we partner with you to advance this mission through effective coalition management, strategic communications and strong relationships with decision-makers at the state and federal levels. We promote the public policy and advocacy agendas of hospitals and health systems, academic medical centers, medical device and life science companies, patient advocacy organizations, membership trade associations, health professional societies and global health groups. With our guidance, clients author and enact legislation; establish new policies and programs; navigate and shape regulatory processes; secure and maintain Medicare reimbursement for new products and technologies; defeat proposals that threaten their priorities; and take action to safeguard their interests. We build bridges with agencies such as the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the Food and Drug Administration (FDA) to help clients secure funding and support for their projects, campaigns and research initiatives. Our team unites diverse stakeholders in coalitions aligned under shared policy goals, develops politically viable policy solutions that advance client goals, and builds awareness and support through grassroots advocacy. We’ve helped clients shape legislative, executive branch and regulatory activity at the highest level.

Faegre Drinker Consulting professionals do not act as attorneys for clients. Learn more about the Faegre Drinker Consulting practice.

Insights & Events

Insights
Updates May 2025

HHS and FDA Launch RFI on Deregulatory Plan — A Key Opportunity to Shape Health and Food Policy

Submissions Through Regulations.gov Due July 14, 2025
4 min read  
Media Mentions May 2025

Nisha Quasba Comments on Drug Importation From Canada in Law360

1 min read  
Media Mentions May 2025

Nisha Quasba Discusses Trump’s Push to Boost Drug Imports in Bloomberg Law

1 min read  
Updates April 2025

Data Security Program, Medicare Advantage, Colorado Insurance Requirements & More

Artificial Intelligence Briefing
8 min read  
Updates April 2025

The Effects of HHS Workforce Reductions, Tariffs on Pharma, the ‘Pill Penalty’ and More

Biopharma & Medical Devices Briefing
5 min read  
Published Articles April 2025

Accuracy of Medicare Information Provided by State Health Insurance Assistance Programs

1 min read  
Published Articles March 2025

A Collaborative Column: Has Practicing Law Really Changed?

The Indiana Lawyer
1 min read  
Published Articles March 2025

Breaking the Silence: Challenges and Opportunities in Pediatric Drug Development

1 min read  
Updates March 2025

NIH Funding Guidance; FDA Reinstates Key Staff Amid Industry Pressure; Make America Healthy Again Commission; and the Latest on Tariffs

Biopharma & Medical Devices Briefing
7 min read  
Updates February 2025

Major Changes Proposed for Health Care Transactions in Indiana: From Attorney General Notice to Approval by State Merger Board

Indiana House Bill 1666 and Proposed ‘Health Care Entity Merger Approval Board’
9 min read  

Related Legal Services

Related Industries